Editorial [Hot Topic: Recombinant Adeno-Associated Virus: Current Achievements and Limitations (Guest Editor: Philippe Moullier)]

Philippe      Moullier

doi:10.2174/1566523054065002

Download Options

Rights & Permissions Print Cite

Current Gene Therapy

Title: Editorial [Hot Topic: Recombinant Adeno-Associated Virus: Current Achievements and Limitations (Guest Editor: Philippe Moullier)]

Volume: 5 Issue: 3

Author(s): Philippe Moullier

Affiliation:

Export Options

Export File:

RIS (for EndNote, Reference Manager, ProCite)

BibTeX

Text

Content:

Citation Only

Citation and Abstract

About this article

Cite this article as:

Moullier Philippe, Editorial [Hot Topic: Recombinant Adeno-Associated Virus: Current Achievements and Limitations (Guest Editor: Philippe Moullier)], Current Gene Therapy 2005; 5 (3) . https://dx.doi.org/10.2174/1566523054065002

DOI https://dx.doi.org/10.2174/1566523054065002	Print ISSN 1566-5232
Publisher Name Bentham Science Publisher	Online ISSN 1875-5631

About this journal

Call for Papers in Thematic Issues

Submission closes on : ---

Programmed Cell Death Genes in Oncology: Pioneering Therapeutic and Diagnostic Frontiers (BMS-CGT-2024-HT-45)

Programmed Cell Death (PCD) is recognized as a pivotal biological mechanism with far-reaching effects in the realm of cancer therapy. This complex process encompasses a variety of cell death modalities, including apoptosis, autophagic cell death, pyroptosis, and ferroptosis, each of which contributes to the intricate landscape of cancer development and ...read more

Guest Editor(s): Hao Chi